NCT03385369View on ClinicalTrials.gov

A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 5, 2018

Primary Completion Date

April 12, 2018

Study Completion Date

April 12, 2018

Conditions
SafetyHealthy Subjects
Interventions
DRUG

MEDI0382

Single dose of MEDI0382

DRUG

Placebo

Single dose of placebo

Trial Locations (1)

92801

Research Site, Anaheim

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY